We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SUN:NYSESunoco LP Analysis

Data as of 2026-09-16 - not real-time

$79.97

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At $79.97, Sunoco LP shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Across the trailing 30 sessions it gained 3.3%. Momentum indicators put RSI at 63.1 (approaching overbought) with MACD reading bullish. Price has been bracketed by support at $73.59 and resistance at $80.20.
Valuation screens as fair: a P/E of 17.7 sits in line with the sector average of 18.3. The average analyst target implies 3.8% above today's level. Revenue is growing at 164.5% on a 2.9% profit margin. The 5.01% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 31.1%, a beta of -0.34 and a maximum drawdown of 14.0%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.

Top Market Events

Here is how Sunoco LP SUN and Talos Energy TALO have performed compared to their sector so far this year.4dUpdate On Sunoco As The Stock Migrates From New York To TexasExplore why Sunoco LP is rated Buy: soaring refining...Sunoco LP stock trades in the mid-$70s range, backed by strong recent revenue, steady quarterly EPS,

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 65.22
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 17.7 versus sector average of 18.3
  • Trading above the 200-day average of 65.22

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 17.7 versus sector average of 18.3
  • Revenue growth of +164.5%
  • Return on equity of 18.7%

Key Metrics & Analysis

Financial Health

Revenue Growth164.50%
Profit Margin2.93%
P/E Ratio17.7
ROE18.66%
ROA5.50%
Debt/Equity177.78
P/B Ratio1.6
Op. Cash Flow$2.3B
Free Cash Flow$919.9M
Industry P/E18.3

Technical Analysis

TrendBullish
RSI63.1
Support$73.59
Resistance$80.20
MA 20$76.40
MA 50$74.69
MA 200$65.22
MACDBullish
VolumeIncreasing
Fear & Greed Index91.45

Valuation

Fair Value$88.89
Target Price$83.00
Upside/Downside3.79%
GradeFair
TypeBlend
Dividend Yield5.01%

Risk Assessment

Beta-0.34
Volatility31.05%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.